Grunenthal GmbH - Company Profile
Powered by 
All the sales intelligence you need on Grunenthal GmbH in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Grunenthal GmbH fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Grunenthal GmbH.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Grunenthal GmbH’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Grunenthal GmbH's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Gabriel Baertschi
Chief Executive Officer Senior ManagementMr. Gabriel Baertschi has been the Chief Executive Officer of the company since 2016. Prior to this, he served as the President of AstraZeneca Germany and he also served as the Country Manager of AstraZeneca. Previously, she served as the Member of the Board of MedXCell.
Fabian Raschke
Chief Financial Officer Senior ManagementMr. Fabian Raschke has been the Chief Financial Officer of the company since 2019. Prior to this, he was the Member of the Corporate Executive Board. Previously, Mr. Fabian served as the Head Group Controlling of the company from 2016 to 2019. He also served as Head Controlling & Corporate Development at Xella Group.
Uli Brodl, M.D.
Chief Scientific Officer Senior ManagementMr. Uli Brodl has been the Chief Scientific Officer of the company since February 2025. Previously, he was the Corporate Senior Vice President and Head of Global Clinical Development & Operations at Boehringer Ingelheim.
Jan Adams, MD
Chief Commercial Officer Senior ManagementMr. Jan Adams has been the Chief Commercial Officer of the company since 2024. Prior to this, he served as the Chief Scientific Officer, Head of Corporate Strategy and Portfolio Management of the company. Previously, he served leadership roles at Novartis, Takeda, and McKinsey & Company.
Par Johansson
Chairman Non Executive BoardDr. Par Johansson has been the Chairman of the Supervisory Board of the company. Prior to this, he was the Managing Partners in law firm of Heuking Kuhn Luer Wojtek in 1999. Currently, he also serves as the Chief Financial Officer of the law firm.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer